Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma

Cancer Research

Volumn 63, Issue 16, 2003, Pages 5021-5027

  Farazi, Paraskevi A ^a,b   Glickman, Jonathan ^c   Jiang, Shan ^a   Yu, Alice ^a   Rudolph, Karl Lenhard ^a,d   DePinho, Ronald A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; DIETHYLNITROSAMINE; PROTEIN P53; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CELL TYPE; CHROMOSOME; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; HISTOPATHOLOGY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; TELOMERE; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; LIVER NEOPLASMS; MALE; MICE; PROLIFERATING CELL NUCLEAR ANTIGEN; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0042440603     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Badvie, S. Hepatocellular carcinoma. Postgrad. Med. J., 76: 4-11, 2000.
2. Thorgeirsson, S. S., and Grisham, J. W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet., 31: 339-346, 2002.
3. Rudolph, K. L., DePinho, R. A. Telomeres and Telomerase in Experimental Liver Cirrhosis. In: A. I. M. (ed.), The Liver Biology and Pathobiology, Fourth edition, pp. 1001-1011. Philadelphia: Lippincott Williams and Wilkins, 2001.
4. Miura, N., Horikawa, I., Nishimoto, A., Ohmura, H., Ito, H., Hirohashi, S., Shay, J. W., and Oshimura, M. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet. Cytogenet., 93: 56-62, 1997.
5. Urabe, Y., Nouso, K., Higashi, T., Nakatsukasa, H., Hino, N., Ashida, K., Kinugasa, N., Yoshida, K., Uematsu, S., and Tsuji, T. Telomere length in human liver diseases. Liver, 16: 293-297, 1996.
6. Kitada, T., Seki, S., Kawakita, N., Kuroki, T., and Monna, T. Telomere shortening in chronic liver diseases. Biochem. Biophys. Res. Commun., 211: 33-39, 1995.
7. Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., and Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J., 16: 935-942, 2002.
8. Artandi, S. E., Chang, S., Lee, S. L., Alson, S., Gottlieb, G. J., Chin, L., and DePinho, R. A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (Lond.), 406: 641-645, 2000.
9. O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., and DePinho, R. A. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell, 2: 149-155, 2002.
10. Maser, R. S., and DePinho, R. A. Connecting chromosomes, crisis, and cancer. Science (Wash. DC), 297: 565-569, 2002.
11. Nagao, K., Tomimatsu, M., Endo, H., Hisatomi, H., and Hikiji, K. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma. J. Gastroenterol., 34: 83-87, 1999.
12. Kobayashi, T., Kubota, K., Takayama, T., and Makuuchi, M. Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy. Am. J. Surg., 181: 284-288, 2001.
13. Hytiroglou, P., Kotoula, V., Thung, S. N., Tsokos, M., Fiel, M. I., and Papadimitriou, C. S. Telomerase activity in precancerous hepatic nodules. Cancer (Phila.), 82: 1831-1838, 1998.
14. Tahara, H., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J. W., Tahara, E., Kajiyama, G., and Ide, T. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res., 55: 2734-2736, 1995.
15. Youssef, N., Paradis, V., Ferlicot, S., and Bedossa, P. In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis. J. Pathol., 194: 459-465, 2001.
16. Ogami, M., Ikura, Y., Nishiguchi, S., Kuroki, T., Ueda, M., and Sakurai, M. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Lab. Investig., 79: 15-26, 1999.
17. Zhang, R., Wang, X., Guo, L., and Xie, H. Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase. Int. J. Cancer, 97: 173-179, 2002.
18. Sandgren, E. P., Palmiter, R. D., Heckel, J. L., Brinster, R. L., and Degen, J. L. DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice. Proc. Natl. Acad. Sci. USA, 89: 11523-11527, 1992.
19. Edwards, J. E., and Dalton, A. J. Induction of cirrhosis of the liver and of hepatomas in mice with carbon tetrachloride. J. Natl. Cancer Inst., 3: 19-41, 1942.
20. Castro, G. D., Diaz Gomez, M. I., and Castro, J. A. DNA bases attack by reactive metabolites produced during carbon tetrachloride biotransformation and promotion of liver microsomal lipid peroxidation. Res. Commun. Mol. Pathol. Pharmacol., 95: 253-258, 1997.
21. Vesselinovitch, S. D., and Mihailovich, N. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res., 43: 4253-4259, 1983.
22. Vesselinovitch, S. D., Koka, M., Mihailovich, N., and Rao, K. V. N. Carcinogenicity of diethylnitrosamine in newborn, infant, and adult mice. J. Cancer Res. Clin. Oncol., 108: 60-65, 1984.
23. Blasco, M. A., Lee, H. W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., and Greider, C. W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91: 25-34. 1997.
24. Rudolph, K. L., Chang, S., Lee, H. W., Blasco, M., Gottlieb, G. J., Greider, C., and DePinho, R. A. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell, 96: 701-712, 1999.
25. Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S. L., Gottlieb, G. J., Greider, C. W., and DePinho, R. A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 97: 527-538, 1999.
26. Greenberg, R. A., Chin, L., Femino, A., Lee, K. H., Gottlieb, G. J., Singer, R. H., Greider, C. W., and DePinho, R. A. Short dysfunctional telomeres impair tumorigenesis in the INK4a(δ2/3) cancer-prone mouse. Cell, 97: 515-525, 1999.
27. Rudolph, K. L., Millard, M., Bosenberg, M. W., and DePinho, R. A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet., 28: 155-159, 2001.
28. Gonzalez-Suarez, E., Samper, E., Flores, J. M., and Blasco, M. A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet., 26: 114-117, 2000.
29. Chang, S., Khoo, C. M., Naylor, M. L., Maser, R. S., and DePinho, R. A. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev., 17: 88-100, 2003.
30. Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., and DePinho, R. A. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science (Wash. DC), 287: 1253-1258, 2000.
31. Okuda, K. Hepatocellular carcinoma. J. Hepatol., 32: 225-237. 2000.
32. Maser, R. S., and DePinho, R. A. Take care of your chromosomes lest cancer take care of you. Cancer Cell, 3: 4-6, 2003.
33. Lee, H. W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., 2nd, Greider, C. W., and DePinho, R. A. Essential role of mouse telomerase in highly proliferative organs. Nature (Lond.), 392: 569-574, 1998.
34. van Heek, N. T., Meeker, A. K., Kern, S. E., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Offerhaus, G. J., Hicks, J. L., Wilentz, R. E., Goggins, M. G., De Marzo, A. M., Hruban, R. H., and Maitra, A. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am. J. Pathol., 161: 1541-1547, 2002.
35. Wong, K. K., Maser, R. S., Bachoo, R. M., Menon, J., Carrasco, D. R., Gu, Y., Alt, F. W., and DePinho, R. A. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature (Lond.), 421: 643-648, 2003.
36. Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., and Cerutti, P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science (Wash. DC), 264: 1317-1319, 1994.
37. Bressac, B., Kew, M., Wands. J., and Ozturk, M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
38. Ozturk, M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338: 1356-1359, 1991.
39. Prives, C., and Hall, P. A. The p53 pathway. J. Pathol., 187: 112-126, 1999.